The FDA has approved risperidone once-monthly, extended-release injectable suspension for maintenance treatment of bipolar I ...
Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the best high volume stocks to buy according to Wall Street ...
The Food and Drug Administration (FDA) has approved Uzedy ® (risperidone extended-release injectable suspension) as monotherapy or as adjunctive therapy to lithium or valproate for the maintenance ...
MedPage Today on MSN
Risperidone OK'd for Bipolar I; Stockholm Syndrome Inspo Dies; Bella Hadid's Battle
The FDA expanded the approval of once-monthly risperidone (Uzedy) to include adjunct treatment for bipolar I disorder, ...
This is a developing news story. Please check back soon for updates. The FDA approved extended-release Uzedy for the ...
Purposeful prescribing is the idea of making thoughtful, patient-centred decisions about medication – choices that reflect ...
When Natasha Tracy was 19, a psychiatrist diagnosed her with minor depression. “I knew this was wrong,” Tracy says. “He hadn’t listened to me. I was suffering from severe, suicidal depression.” In ...
World Mental Health Day 2025 is an opportunity to raise awareness about mental health conditions like bipolar disorder that ...
People living with bipolar disorder face stigma and treatment challenges. Despite these barriers, it’s possible to live a full and productive life with the condition. Four people share their stories.
While borderline personality disorder and bipolar disorder share common symptoms like reckless behavior, there are a few key ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results